This inventor holds 1 USPTO granted patent. Top assignee: National Institute of Health and Medical Research. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Jacqueline Lule: Innovator in Vaccine Development
Introduction
Jacqueline Lule is a prominent inventor based in Plaisance du Touch, France. She has made significant contributions to the field of medical research, particularly in vaccine development. Her innovative work focuses on the cytomegalovirus (CMV), which poses a considerable health risk.
Latest Patents
Jacqueline Lule holds a patent for a fusion protein that comprises the whole or part of the PP65 protein of human CMV. This invention is particularly useful for preparing a vaccine. The fusion protein is characterized by including at least part of the pp65 protein of CMV or a protein with at least 80% homology to it, combined with at least a second peptide fragment derived from CMV. Additionally, the patent covers a nucleotide sequence coding for such a protein and a pharmaceutical composition containing it. The invention also outlines its use as medicine and a method for preparing the protein.
Career Highlights
Jacqueline Lule is affiliated with the National Institute of Health and Medical Research, where she continues her groundbreaking work in the field of virology and immunology. Her research has the potential to impact public health significantly by advancing vaccine technology.
Collaborations
Jacqueline has collaborated with notable colleagues, including Eric Prieur and Jean-Luc Davignon. These partnerships enhance her research efforts and contribute to the advancement of medical science.
Conclusion
Jacqueline Lule is a dedicated inventor whose work in vaccine development is paving the way for innovative solutions to combat viral infections. Her contributions to the field are invaluable and highlight the importance of research in improving public health.